Access to migraine treatment and the economic impact of migraine

That this House recognises that migraine is a serious neurological condition affecting over 10 million people in the UK; notes that migraine remains under-recognised, leading to a significant impact on the lives of those who are affected, including their ability to work and contribute to the economy; acknowledges that migraine costs the UK economy an estimated £8.8 billion per year due to absenteeism and presenteeism; further notes that access to migraine care remains inconsistent across NHS regions, exacerbating health inequalities; and calls on the Government to assess the burden of migraine as part of the economic productivity agenda, and integrate migraine into workforce and productivity strategies.